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Cox regression is used to estimate exposure–response models (with cumulative 1,3-butadiene (BD) ppm-
years as the exposure metric) based on the most recent data and validated exposure estimates from UAB’s
study of North American workers in the styrene–butadiene–rubber industry. These data are substantially
updated from those in USEPA’s 2002 risk assessment.
The slope for cumulative BD ppm-years is not statistically signiﬁcantly different than zero for CML,
AML, or, when any one of eight exposure covariates is added to the model, for all leukemias combined
(total leukemia).
For total leukemia, the EC(1/100,000) is approximately 0.15 BD environmental ppm and the corre-
sponding unit risk factor is approximately 0.00007 per BD environmental ppm. The excess risk for
CML is approximately 15-fold less than for total leukemia. The maximum likelihood estimates suggest
that there is no excess risk for AML from cumulative BD ppm-years.
For CLL, the slope is statistically signiﬁcantly different than zero. The excess risk for CLL is approxi-
mately 2.5-fold less than for total leukemia.
For both total leukemia and CLL, the slope is not statistically signiﬁcantly different than zero when the
exposure–response modeling is based on the person-years with cumulative BD ppm-years less than or
equal to 300 ppm-years.
 2011 Elsevier Inc. Open access under CC BY-NC-ND license.1. Introduction
Numerous publications have examined the evidence related to
1,3-butadiene (BD) and carcinogenicity in worker populations.
These publications relate to ﬁve independent cohorts used primar-
ily for long-term mortality cohort studies: a diverse rubber manu-
facturing plant in Ohio (e.g., McMichael et al., 1976), three different
facilities involving monomer production (e.g., Divine and Hartman,
2001), and multi-center studies of largely overlapping cohorts of
styrene–butadiene–rubber (SBR) workers (e.g., Delzell et al., 2006).
For the purposes of exposure–response modeling, quantitative
exposure information is critical – not only on the chemical of con-
cern (here, BD), but also on potential confounding exposures (here,
styrene (STY), benzene, and dimethyldithiocarbamate (DMDTC)).
In this regard, the University of Alabama at Birmingham (UAB) epi-
demiological study of North American male workers in the SBR
industry provides the best available data. For the other studies,
the exposure information is limited and generally qualitative. For
example, in the recent monomer studies the exposure has beenc@aol.com (R.L. Sielken).
-NC-ND license.characterized by a qualitative cumulative exposure score based
on job classes, calendar time, and length of time in the job, and
there were no data available on the peak exposures (Divine and
Hartman, 2001).
Sections 7.4, 8.2.4.2, and 10.1.1 in the 2002 USEPA ‘‘Health
Assessment of 1,3-Butadiene’’ contain an extensive discussion of
the studies related to BD workers and concluded that the UAB data
provided the best published set of data to evaluate human cancer
risk from BD inhalation exposure (USEPA, 2002). In 2009, the Texas
Commission on Environmental Quality (TCEQ) reviewed the
scientiﬁc literature and concluded that there were no other
epidemiology studies that would be appropriate to evaluate hu-
man cancer risk from BD inhalation exposure (Grant et al. 2009).
To date, there have been three editions of the UAB epidemi-
ological study database. The 1995 epidemiological data set (ﬁnd-
ings published in Delzell et al. 1996) included the original
estimates of exposure for six of the eight plants and follow-up
for workers from all eight plants through December of 1991.
The 2000 edition of the epidemiological data set (Delzell et al.
2000, 2001) included revised estimates of exposure. The 2004
edition of the data (ﬁndings published in Cheng et al. 2007
and elsewhere) includes seven more years of follow-up than
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sure estimates.
1995 Data Set – In 1995, Delzell et al. (1995) reported analyses
(based on the exposure estimates described in Macaluso et al.
1996) performed in 17,964 men who worked at eight plants
located in North America. All eight plants produced styrene–
butadiene–rubber and related products. A majority (92%) of
the 17,964 men had exposure history and could be used in
exposure–response modeling.
2000 Data Set – In a 2000 report (published in 2004), Macaluso
et al. indicated that the original exposure estimates (reported in
1995) were low and reported new extensively changed expo-
sure estimates developed over approximately ﬁve years in a
multi-phase review including two new sets of plant visits. The
review involved plant engineering and technical staffs and an
independent panel of industry experts including industrial
hygienists, epidemiologists, and engineers. The review identi-
ﬁed new tasks for which exposure estimates were needed,
made the exposure scenarios more speciﬁc by separating multi-
ple tasks previously grouped into broadly deﬁned background
exposures, developed further questions about operations and
exposure potential, provided reference materials on emission
rates from pumps, compressors, and tank vents, provided mea-
surements and reﬁned estimates of airﬂow, and recommended
changes in assumptions, parameters, and models used to esti-
mate exposures. The relative ranking of exposures across work-
ers was largely unchanged. However, the upper 50% of the
distribution of task- and calendar-year-speciﬁc exposure esti-
mates shifted upwards. The median cumulative exposure to
BD was almost ﬁve times higher than the original estimate.
The revised BD exposure estimates are up to one order of mag-
nitude greater than the original estimates, particularly for the
1940–1960s. The revised STY exposures also increased but not
as much as the BD exposures did. In 2000, UAB also developed
estimates of exposures to DMDTC and additional measures of
BD and STY exposures. Speciﬁcally, the BD and STY exposure
estimates were expanded to include a new deﬁnition of ‘‘peak’’
exposures and the exposures to BD and STY were partitioned
into exposures either above or below a nominal threshold of
100 ppm for BD and 50 ppm for STY.
2004 Data Set – In 2004, the UAB updated the epidemiological
data to include seven more years of follow-up (through 1998)
and the most recent estimates of exposures developed in 2000
(Sathiakumar et al. 2005). The 2004 epidemiological data
includes 81 decedentswith leukemia as opposed to 58 decedents
with leukemia in the1995and2000data sets. In the2004data set
there are a total of 16,585 workers and 5593 decedents with
exposure estimates for BD, STY and DMDTC. Exposure estimates
are available for 6 of the 8 plants, and the exposure–response
modeling is based on these 6 plants. Additionally, a substantial
effortwasmade to validate the BDexposure estimates developed
by Macaluso et al. (2004) against job- and calendar-year speciﬁc
exposure-monitoring measurements from 1977 to 1991 at the
largest of the six plants (Sathiakumar et al. 2007). This validation
plant was the only plant with both typical SBR operations and
extensive other operations.Most of the other ﬁve plants had typ-
ical SBR operations only. Sathiakumar et al. stated that the expo-
sure misclassiﬁcation may have been more severe at the
validation plant, and that, although the general procedures for
estimating exposure were the same for all six plants, data on
determinants of exposurewere plant-speciﬁc. For jobs that were
well-deﬁned by a speciﬁc set of tasks and typically found in all
SBR plants, the correlation between estimates and measure-
ments was relatively high (0.81), and the difference (measure-
ment–estimate) was noticeably greater in the earlier years(1977–1983) and much smaller in the later years (1984–1991).
For BD ppm, over all years combined, the measurements and
estimates had means 11.3 and 6.0, respectively, and medians
2.9 and 0.23, respectively.
The 2002 USEPA assessment was based on the original exposure
data developed prior to 1996. Although the EPA has not updated its
assessment, the UAB researchers, TCEQ, and Sielken & Associates
have all based their more recent analyses on the most recent
updated data. Sielken & Associates was greatly impressed by the
considerable efforts made by UAB during the exposure re-
evaluation and strongly believes that the revised exposure
estimates are much more appropriate for exposure–response
analyses than the original estimates.
Mortality from leukemia and other lymphohematopoietic can-
cers has consistently been the health endpoint of interest. Early
analyses of mortality from all causes, all cancers, and lymphosar-
coma (currently classiﬁed as non-Hodgkin’s lymphoma (NHL))
and cancer incidence did not indicate increases associated with
occupational exposures to BD (Delzell et al. 1996). Herein, leuke-
mia (total leukemia) and three subclassiﬁcations of leukemia
(acute myelogenous leukemia (AML), chronic lymphocytic leuke-
mia (CLL), and chronic myelogenous leukemia (CML)) will each
be considered. These three subclassiﬁcations are considered
because they have been previously identiﬁed as potentially of
interest and there are sufﬁcient mortalities with each of these
endpoints for model ﬁtting and risk characterization.2. Methods
While it is generally agreed that BD produces toxicity when it is
metabolized to its reactive metabolites after exposure, the data
needed to conduct a detailed mechanism of action analysis and
construct an accepted biologically based exposure–response model
are not available (Grant et al. 2009).
The statistical exposure–response modeling herein is done sep-
arately for total leukemia, AML, CLL, and CML mortality. Although
the regulation of environmental BD inhalation exposure has thus
far been based on cumulative BD ppm-years (USEPA (2002) and
TCEQ (Grant et al., 2009)), the 2004 UAB data set also contains ﬁve
non-exposure variables (age, years since hire, calendar year, race,
and plant) and eight other exposure variables (cumulative STY
ppm-years, cumulative DMDTC mg/cm-years, cumulative number
of BD high intensity tasks (HITs), cumulative number of STY HITs,
cumulative ppm-years with BD 6100 ppm, cumulative ppm-years
with BD >100 ppm, cumulative ppm-years with STY 650 ppm, and
cumulative ppm-years with STY >50 ppm). Each worker’s exposure
history is partitioned into person-years based on UAB’s plant and
calendar year speciﬁc job-exposure-matrix (JEM). Each person-
year has an associated value for all exposure and non-exposure
variables. Cox regression modeling of these person-years is used
to estimate the roles of cumulative BD ppm-years and the other
exposure and non-exposure variables with respect to the response.
For each occurrence of the speciﬁed response, Cox regression notes
the age of the corresponding worker, evaluates the proportion of
the workers with that response among the set of all workers at risk
at that age, and models the impacts of the exposure and non-expo-
sure variables on these proportions. Cox regression (unlike Poisson
regression) incorporates each speciﬁc age rather than categories of
age and allows cumulative BD ppm-years to be treated as a contin-
uous variable rather than being required to be grouped into catego-
ries. Maximum likelihood criteria are used to judge statistical
signiﬁcance at the 5% signiﬁcance level.
Exposure–response modeling considered both simple lags (in
which exposures in the preceding speciﬁed number of years are
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exposures in the preceding speciﬁed number of years are excluded
in addition to excluding exposures more than a speciﬁed number
of years into the past).
The primary excess risk characterization is the estimated effec-
tive concentration (EC) in environmental ppm concentrations cor-
responding to an extra risk of 1/100,000 and the unit risk factor
(URFmle) corresponding to a linear extrapolation below the EC(1/
100,000). The secondary excess risk characterization is the 95%
lower conﬁdence limit (LEC(1/100,000)) on the concentration cor-
responding to an extra risk of 1/100,000 and the upper-bound unit
risk factor (URFub) corresponding to a linear extrapolation below
the LEC(1/100,000).
Life-table methods are used to calculate excess risks (ECs and
LECs). These calculations are sequential calculations beginning at
age zero that step through the years in a lifetime. The calculation
incorporates the background age-speciﬁc hazard rate for all-cause
mortality, the background age-speciﬁc hazard rate for the speciﬁed
response, the age-speciﬁc values for the exposure metrics, and the
corresponding Cox exposure–response model (i.e., the age-speciﬁc
multiplier of the background age-speciﬁc hazard rate for the spec-
iﬁed response determined by the Cox exposure–response model
and the values of the age-speciﬁc exposure metrics).
Although the details in the calculations of ECs, and LECs can dif-
fer among authors, the preferred BEIR IV methodology (NRC, 1988)
is used herein to do the life-table calculations. Also, the calcula-
tions include recent US survival rates (Arias, 2010) and recent leu-
kemia mortality rates (2005 mortality from CDCWONDER – http://
wonder.cdc.gov/cancermort-v2005.HTML – accessed on June 29,
2010). Furthermore, the ECs and LECs are calculated using the
methodology and default age-dependent adjustment factors
(ADAFs) described in USEPA 2005a,b (see also Sielken and Val-
dez-Flores (2008) (Appendix 5) and Sielken and Valdez-Flores
(2009)).
3. Exposure–response models for total leukemia
Table 1 identiﬁes the features of the occupational exposures
that make a statistically signiﬁcant improvement in the Cox mod-
el’s ability to predict occupational leukemia by including a second
variable (given that cumulative BD ppm-years is the ﬁrst variable).
Table 1 indicates that any one ofTable 1
Total leukemia: Increase in the maximum log likelihood when one of the non-exposure or e
being a log-linear function of cumulative BD ppm-years: Statistically signiﬁcant increases
a Cox model with only cumulative BD ppm-years.
b Categories for years since hire and Calendar year were based on quintiles of leukem
cumulative exposures were partitioned as controls and quintiles of exposed leukemia d
⁄ Statistically signiﬁcant improvement in the likelihood at the 5% signiﬁcance level.
⁄⁄ Statistically signiﬁcant improvement in the likelihood at the 1% signiﬁcance level.1) cumulative DMDTC mg/cm-years,
2) cumulative BD HITs,
3) cumulative STY HITs,
4) cumulative ppm-years with BD >100 ppm,
5) cumulative ppm-years with STY 650 ppm, and
6) cumulative ppm-years with STY >50 ppm
makes a statistically signiﬁcant improvement in the maximum
likelihood if that single covariate is added to the exposure–
response model with cumulative BD ppm-years as the predictive
variable. These six covariates are not part of the regulated environ-
mental exposures; therefore, it is important that the occupational
leukemia risk attributed to cumulative BD ppm-years be adjusted
to account for the effects that other co-occurring exposures may
have on the occupational leukemia risk.
Some previous BD and STY exposure characterizations have in-
cluded ‘‘peaks.’’ However, the term ‘‘peaks’’ can be misleading be-
cause the variable actually refers to the ‘‘number of high-intensity
tasks (HITs)’’ rather than the speciﬁc numerical value of the max-
imum ppm exposure level. Also, HITs was deﬁned one way in
1995 and then redeﬁned in 2000. In 1995, HITs was deﬁned by
evaluating task-speciﬁc and background exposures to determine
the number of 15 min periods in a shift during which the average
intensity of exposure was at or above a threshold (100 ppm for
butadiene and 50 ppm for styrene) and then this number of
high-intensity tasks per shift was multiplied by 225 (days at work
in a year) to obtain the annual HITs value (Delzell et al. 1995). In
2000, HITs was redeﬁned as ‘‘...multiplying the per-shift frequency
of tasks entailing exposure >100 ppm (for BD) and >50 ppm (for
STY) by 225 shifts/year’’ (Macaluso et al. 2004). In the 2000 deﬁni-
tion, the 15 min averaging period in the 1995 deﬁnition was elim-
inated – ‘‘To capture high exposures of very short duration, this
deﬁnition did not take exposure duration into account’’ (Macaluso
et al. 2004). With regard to the 100 and 50 ppm levels, ‘‘These arbi-
trary values for the peak threshold appear sensitive enough to cap-
ture intensity and speciﬁc enough to exclude small excursions
compatible with the imprecision of our estimation procedures’’
(Macaluso et al. 2004).
The statistical analysis of covariates herein only gives a limited
indication of the possible improvement in the Cox model’s ability
to predict leukemia if the model based on cumulative BD
ppm-years is expanded to include other variables. The statisticalxposure covariates is added to the Cox proportional hazards model with the rate ratio
are shaded.
ia decedents, and race was categorized as black and others, while covariates for
ecedents.
R.L. Sielken Jr., C. Valdez-Flores / Regulatory Toxicology and Pharmacology 60 (2011) 332–341 335analysis is not a biological or mechanistic analysis and only consid-
ers the simplest linear model for the effects of these variables indi-
vidually. As is clear from Fig. 1, which shows the joint relationship
between cumulative BD ppm-years and the cumulative number of
BD HITs at the end of follow-up, the relationship between variables
goes well beyond correlation and is not simple. These two corre-
lated variables can jointly contribute to the Cox’s models ability
to predict leukemia (as evidenced by the statistically signiﬁcant in-
crease in the maximum likelihood when BD HITs is added to the
model). Several variables may in fact be involved in the observed
leukemia.
Table 2 indicates the excess risk characterizations for total
leukemia based on the most scientiﬁcally defensible exposure–
response modeling of the effect of cumulative BD ppm-years
either alone or after adjusting for the effects of a statistically
signiﬁcant covariate. The average and geometric mean of the
EC(1/100,000)s and corresponding URFmles are approximately
0.15 ppm environmental BD and 0.00007 per ppm environmental
BD, respectively – either for the six models with an added covar-
iate or all seven models (including the model with no covariate).
The average and geometric mean of the LEC(1/100,000)s and
URFub are approximately 0.06 ppm and 0.00016 per ppm, respec-
tively. The benchmark response level of 1/100,000 (rather than,
say, 1/million) was chosen so that the EC and LECs would still
be in the heart of the observed data and not be unnecessarily
dependent upon the assumed shape of the exposure–response
model.
In order for the ECs and LECs to be reasonable points of
departure (PODs), they need to be in the midst of the study data
and not too close to zero. There were 12,819 exposed workers
among the 16,585 workers in the entire cohort. Of the 81 leuke-
mia mortalities, there were 71 among the exposed workers. The
BD ECs and LECs in Table 2 are all between 0.05 and 0.22 envi-
ronmental ppm. These environmental ppm concentrations are
equivalent to 10.65 and 46.85 occupational BD ppm-years
assuming that the environmental exposure was for 70 years.
Among the 12,819 exposed workers, 22% have cumulative BD
ppm-years at the end of their follow-up less than 10.65 occupa-
tional BD ppm-years, and these workers had 7% of the corre-
sponding 71 leukemia mortalities. Also, among the 12,819
exposed workers, 47% have cumulative BD ppm-years at the
end of their follow-up less than 46.85 occupational BD ppm-
years, and these workers had 34% of the corresponding 71 leuke-
mia mortalities. Thus, the ECs and LECs in Table 2 corresponding
to an extra risk of 1/100,000 are well within the range of the
cumulative BD exposures observed in the UAB epidemiological
data.Fig. 1. Scatter plot of the cumulative BD ppm-years and the cumulative number of
BD HITs at the time of follow-up for all workers.4. Results for acute myelogenous leukemia, chronic
lymphocytic leukemia, and chronic myelogenous leukemia
The leukemia diagnoses among workers were pathologically
conﬁrmed by Delzell et al. (2006) based on medical records. The
81 leukemia deaths observed in the UAB data were classiﬁed as
one of nine mutually exclusive types.Category Description Number ICD91 Acute lymphocytic leukemia 3 204.0
2 Acute myelogenous or
monocytic leukemia
26 205.0,
206.0
3 Acute leukemia – other/
unknown
4 207.04 Chronic lymphocytic
leukemia25 204.15 Chronic myelogenous
leukemia16 205.16 Chronic leukemia – other/
unknown1 207.17 Non-AML – unspeciﬁed
lymphocytic2 204.98 Non-AML – unspeciﬁed
myelogenous3 205.99 Non-AML – other non-AML/
unknown1 207.8Three of these nine types (acute myelogenous leukemia (AML)
(category 2), chronic lymphocytic leukemia (CLL) (category 4),
and chronic myelogenous leukemia (CML) (category 5)) are well-
deﬁned endpoints and include sufﬁcient numbers of decedents in
the UAB data to develop models and analyses similar to those used
above for total leukemia. Table 3 shows the excess risk character-
izations for AML, CML, and CLL we obtained with the same expo-
sure–response modeling methodology used for total leukemia.
Leukemia and the CLL, CML, and AML subsets were also analyzed
in Graff et al. 2005, although the focus there was on relative rates
(RRs) for speciﬁed exposure categories and no exposure–response
models were estimated.
Sensitivity analyses of the modeling and excess risk character-
izations to either including or excluding other/unknown and
unspeciﬁed leukemia types as part of the three well-deﬁned leuke-
mia types (i.e., AML, CML, and CLL) were performed. (Adding cate-
gories 3 or 8 or both to AML, adding categories 6 or 7 or both to
CLL, and adding categories 6 or 8 or both to CML were evaluated.)
The sensitivity analyses show that these subtypes hardly change
the results.
5. Discussion
The primary objective herein is to develop, identify and provide
scientiﬁc support for the best, most scientiﬁcally defensible
point estimate of excess risk. A secondary objective is to describe
how this point estimate ﬁts in with the other available
estimates.
All estimates in Sections 3 and 4 are based on the most recent
data from the preferred occupational epidemiological study. In
addition, the scientiﬁc defensibility of these estimates stems from
being based on (1) Cox rather than Poisson regression, (2) consid-
eration of both non-exposure and exposure covariates and
their interaction with the cumulative BD ppm-years exposure
metric, (3) the more ﬂexible treatment of these co-variables as
categorical variables using nonparametric techniques rather
than as continuous variables using parametric techniques, (4)
Table 2
Excess risk characterizations for total leukemia: Models ordered with the largest maximum log likelihood ﬁrst and the smallest maximum log likelihood last: Models with
maximum log likelihoods statistically signiﬁcantly improved over the maximum log likelihood for the model with exposure characterized only by cumulative BD ppm-years are
shaded.
a All models use cumulative BD ppm-years as the predictive dose metric. Some models include categorical covariate effects. The range of positive covariate values is
partitioned into quintiles with approximately equal numbers of leukemia mortalities in each quintile.
b Beta is the coefﬁcient of occupational cumulative BD ppm-years in the exposure–response models. Occupational exposure is assumed to be at 10 m3 per day for 240 days per
year. Environmental exposure is assumed to be at 20 m3 per day for 365 days per year. An environmental ppm-year is assumed to be equivalent to 3.042 occupational ppm-
years [(20/10)  (365/240) = 3.042].
c EC(1/100,000) is the estimated effective concentration (EC) corresponding to an increase in the extra risk of 1/100,000 by age 70. ECs are in environmental ppm and are for
environmental exposures.
d LEC(1/100,000) is the 95% lower conﬁdence limit on the effective concentration (EC) corresponding to an increase in the extra risk of 1/100,000. LECs are in environmental
ppm and are for environmental exposures.
e Slope for a linear extrapolation below EC(1/100,000); namely, slope = 0.00001/EC(1/100,000).
f Slope for a linear extrapolation below LEC(1/100,000); namely, slope = 0.00001/LEC(1/100,000).
g Statistically signiﬁcantly different than zero at the 5% signiﬁcance level.
h Not statistically signiﬁcantly different than zero at the 5% signiﬁcance level.
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exposure rather than mean scored deciles, (5) more thorough
evaluation of the impacts of potential restrictions to the lower
exposure range, and (6) recent exposure validation reported in
Sathiakumar et al. (2007) and our sensitivity analyses that sug-
gest that the slope and corresponding excess risks would be less
under several alternative exposure characterizations based on
Sathiakumar et al. (2007).
The advantages of Cox regression over Poisson regression have
already been mentioned.
5.1. Covariates
The SBR exposure scenarios are fairly complicated and involve
not only potentially important exposures to compounds other than
BD but also highly diverse exposures to BD in terms of magnitude,
intensity, and duration. The exposure characteristics differ sub-
stantially from one work area to another. Some tasks involve very
high intensity exposures of short duration. Very few tasks involve
simple exposures that would allow the effects of different com-
pounds and different intensities and durations to be easily sepa-
rated. Correlation and collinearity among exposure variables
complicates and adversely impacts the exposure–response model-
ing. However, as exempliﬁed by cumulative BD ppm-years and the
cumulative number of BD HITs in Fig. 1, two variables can becorrelated and still contribute different exposure information. So
far, the USEPA has regulated environmental exposure to BD based
solely on cumulative BD ppm-years; therefore, any exposure–
response modeling that hopes to impact such regulations must
include cumulative BD ppm-years. We have used a forward
selection version of stepwise regression to determine the variables
to add to the exposure–response model given the condition that
cumulative BD ppm-years is always part of the model. After
expanding the model from cumulative BD ppm-years to cumula-
tive BD ppm-years plus one other variable, no further addition
made a statistically signiﬁcant increase in the maximum
likelihood.
As indicated in Table 1, none of the non-exposure covariates
(years since hire, calendar year, race, or plant) make a statistically
signiﬁcant improvement in the maximum log likelihood.
The improvements in the maximum log likelihood indicated in
Table 1 for six exposure covariates (DMDTC, BD HITs, STY HITs, BD
>100 ppm, STY 650 ppm, and STY >50 ppm) strongly suggest that,
from a statistical perspective, there are exposure factors other than
cumulative BD ppm-years in the occupational setting potentially
affecting leukemia.
This suggestion is also supported by analyses of the data not
involving exposure–response modeling. For example, consider BD
HITs. All of the 71 exposed workers who had leukemia mortalities
had some BD HITs. None of the 1192 exposed workers without BD
Table 3
Excess risk characterizations for CLL, CML, and AML: Models ordered with the largest maximum log likelihood ﬁrst and the smallest maximum log likelihood last: Models with
maximum log likelihoods statistically signiﬁcantly improved over the maximum log likelihood for the model with exposure characterized only by cumulative BD ppm-years are
shaded.
a All models use cumulative BD ppm-years as the predictive dose metric. Some models include categorical covariate effects. The range of positive covariate values is
partitioned into quintiles with approximately equal numbers of leukemia mortalities in each quintile.
b Beta is the coefﬁcient of occupational cumulative BD ppm-years in the exposure–response models. Occupational exposure is assumed to be at 10 m3 per day for 240 days per
year. Environmental exposure is assumed to be at 20 m3 per day for 365 days per year. An environmental ppm-year is assumed to be equivalent to 3.042 occupational ppm-
years [(20/10)  (365/240) = 3.042].
c EC(1/100,000) is the estimated effective concentration (EC) corresponding to an increase in the extra risk of 1/100,000 by age 70. ECs are in environmental ppm and are for
environmental exposures.
d LEC(1/100,000) is the 95% lower conﬁdence limit on the effective concentration (EC) corresponding to an increase in the extra risk of 1/100,000. LECs are in environmental
ppm and are for environmental exposures.
e Slope for a linear extrapolation below EC(1/100,000); namely, slope = 0.00001/EC(1/100,000).
f Slope for a linear extrapolation below LEC(1/100,000); namely, slope = 0.00001/LEC(1/100,000).
g Statistically signiﬁcantly different than zero at the 5% signiﬁcance level.
h Not statistically signiﬁcantly different than zero at the 5% signiﬁcance level.
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BD HITs is a contributing factor to leukemia. The four potential
alternative explanations for this absence can be dismissed as fol-
lows: First, the distribution of cumulative BD ppm-years at the
end of follow-up is similar for the 1192 exposed workers without
BD HITs and the 11,627 exposed workers with BD HITs. Second,
the location of the 71 leukemia mortalities among exposed work-
ers relative to the distribution of cumulative BD ppm-years at
the end of follow-up is similar for the 1192 exposed workers with-
out BD HITs and the 11,627 workers with BD HITs.
Third, the 9000 workers with BD HITs who had cumulative BD
ppm-years in the same range as the exposed workers without BD
HITs had 58% of the leukemia mortalities among exposed workers.
Thus, if cumulative BD ppm-years were the cause of leukemia mor-
talities, then the 1192 exposed workers without BD HITs had suf-
ﬁcient BD ppm-years to cause leukemia mortalities. However,
they had no leukemia mortalities. Furthermore, if the leukemia
mortality rate (41 out of 9000) among the 9000 workers with BD
HITs who had cumulative BD ppm-years at the end of follow-up
in the same range as the exposed workers without BD HITs were
assumed to apply to the exposed workers without BD HITs, then
more than ﬁve leukemia mortalities would have been expected
among the 1192 exposed workers without BD HITs, and the prob-
ability of observing no leukemia mortalities among these 1192 ex-
posed workers is less than 0.005.
Fourth, the distribution of age at the end of follow-up is similar
for the exposed workers with and without BD HITs. Thus, there is
no substantial difference in age that would explain why exposed
workers without BD HITs had no leukemia mortalities but exposed
workers with BD HITs did have leukemia mortalities.5.2. Treatment of cumulative number of HITs
The number of HITs (BD or STY) depends on the types of jobs
performed by the worker. The observed relationship between
cumulative number of HITs and leukemia is not simple, smooth,
or monotone. Hence, a categorical and nonparametric treatment
of the cumulative number of HITs is less restrictive and more
appropriate than a continuous and parametric treatment.
5.3. Treatment of cumulative BD ppm-years
Because regulatory procedures for environmental risk assess-
ment need to be able to characterize a continuous spectrum of
low levels of BD exposure in a consistent manner, the treatment
of cumulative BD ppm-years in the exposure–response modeling
needs to be parametric. This can be done with cumulative BD
ppm-years either treated as a continuous variable with each work-
er’s speciﬁc exposure value treated as is (untransformed) or trea-
ted as a grouped variable with each worker’s speciﬁc exposure
value transformed to a common value for the group. The dose met-
ric called ‘‘mean scored deciles’’ is an example of the latter treat-
ment. Here, the range of the cumulative BD ppm-years values is
partitioned into 10 groups or categories with approximately equal
numbers of leukemia mortalities. Then, if a worker’s actual cumu-
lative BD ppm-years value at a speciﬁc evaluation time in the Cox
modeling is in the group, then the mean in the group replaces the
worker’s actual cumulative BD ppm-years. The use of ‘‘mean-
scored deciles’’ has been proposed as an attempt to offset exposure
classiﬁcation errors; however, using replacement grouped values
does not improve the estimates of exposure. In addition, early
Table 4
The variability in the risk characterizations (exposure–response model slope and its signiﬁcance) when the exposure–response modeling is restricted to different percentages of
the exposure range.
Cox proportional hazards model with adjustment for HITs
Restricted exposure range Slope (Beta) of exposure–response model Statistical signiﬁcance of slope
Person – years Percentage among 71 leukemia
mortalities with positive
exposures (%)
Percentage
among all
workers (%)
# of
leukemia
mortalities
Maximum
likelihood
estimate
Standard
error
95% Lower
conﬁdence
limit
95% Upper
conﬁdence
limit
Likelihood
ratio test
Wald
test
SSa or
not SS
ALL (69274) 100 100 81 0.00020 0.00013 0.00001 0.00041 0.1931 0.1232 Not SS
67750 100 99.9 81 0.00028 0.00014 0.00004 0.00052 0.1067 0.0529 Not SS
62015 99 99 80 0.00050 0.00040 0.00015 0.00115 0.2282 0.2057 Not SS
61123 95 98 77 0.00058 0.00058 0.00037 0.00153 0.3292 0.3137 Not SS
6401 75 91 63 0.00027 0.00162 0.00240 0.00293 0.8695 0.8698 Not SS
6185 50 81 46 0.00912 0.00483 0.01706 0.00118 0.0437 0.0593 SS and
negative
634 25 55 28 0.02507 0.02667 0.06894 0.01880 0.3349 0.3472 Not SS
a Statistically signiﬁcant at 5% signiﬁcance level.
Fig. 2. The variability in the estimated slope in the exposure–response when the
exposure range is restricted: Exposure–response model excluding HITs.
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resolved in recent publications. Such resolutions greatly reduce
any value of using artiﬁcial replacement values instead of continu-
ous exposures.
5.4. Impacts of restrictions to the lower exposure range
In response to some peer-reviewers’ comments expressing con-
cern over uncertainty in the estimates of job exposure levels andTable 5
Maximum likelihood estimate of the slope for cumulative BD ppm-years (in the Cox propor
only exposure variable), standard error, conﬁdence interval, and statistical signiﬁcance for d
the primary cause of death or a contributing cause of death: Total leukemia.
Cumulative Butadiene ppm-years intervals
included in the estimation
Maximum likelihood
estimate of the slope
Stan
estim
All 0.00029 0.00
61338 ppm-years 0.00121 0.00
61000 ppm-years 0.00145 0.00
6500 ppm-years 0.00296 0.00
6400 ppm-years 0.00283 0.00
6300 ppm-years 0.00305 0.00
6200 ppm-years 0.00089 0.00
6100 ppm-years 0.00224 0.00
* Statistically signiﬁcant at the 5% signiﬁcance level.
** Statistically signiﬁcant at the 1% signiﬁcance level.resultant values of cumulative BD ppm-years, especially at the
highest levels, TCEQ considered Cheng et al.’s exposure–response
modeling restricted to the lower 95% of the exposure range (i.e.,
below the 95th percentile of the cumulative BD ppm-years at the
end of follow-up among the 71 workers with leukemia mortalities
and positive exposure) (Grant, 2008). The problem here is that the
resulting risk characterization is quite variable depending on the
speciﬁc percentage of the exposure range utilized. For example,
two-sided conﬁdence intervals on the slope of cumulative BD
ppm-years expand dramatically (indicating greater uncertainty)
and increasingly suggest non-positive slopes as the exposure range
is restricted (see Table 4 and Fig. 2).
Although thresholds were not explicitly considered in the expo-
sure–response modeling herein, restrictions to the lower exposure
range indicate that there is little to no risk at low exposure levels
and certainly no statistically signiﬁcant increasing exposure–re-
sponse relationship (Tables 5 and 6). This was also previously de-
scribed in Sielken et al. (2007) based on Poisson regression.5.5. Exposure validation and sensitivity analysis
Sathiakumar et al. (2007) addresses the validation of the 1,3-
butadiene exposure estimates for workers at a synthetic rubber
plant. Based on this work, Appendix 7 in TCEQ’s report (Grant,
2008; Grant et al., 2009) provides a sensitivity analysis of BD risk
characterizations to possible exposure estimation errors. Table 7
herein clearly indicates the directionality of the impact of alterna-
tive exposure values (JEM values) on the estimated slope for cumu-
lative BD ppm-years; namely, that the slope and correspondingtional hazards model with cumulative BD ppm-years as a continuous variable and the
ifferent maximum levels of cumulative BD ppm-years for deaths in which leukemia is
dard error of the
ate of the slope
95% Conﬁdence
interval on the slope
Likelihood ratio test that
slope = 0 (p-value)
010 0.00009 0.00049 0.0263*
036 0.00051 0.00191 0.0024**
047 0.00054 0.00236 0.0045**
086 0.00127 0.00465 0.0014**
111 0.00065 0.00501 0.0156*
155 0.00001 0.00609 0.0591
267 0.00434 0.00612 0.7415
536 0.00827 0.01275 0.6793
Table 6
Characteristics of the data sets evaluated in Table 5.
Cumulative butadiene
ppm-years intervals
included in the
estimation
# of
Person
years
Observed # of leukemia
deaths: leukemia is
primary or contributing
cause of death
Observed # of
leukemia deaths:
leukemia is primary
cause of death
Expecteda # of
leukemia deaths:
leukemia is primary
cause of death
SMRb: observed/
expected: leukemia
is primary cause of
death
Powerc to
detect a
slope of
0.005
Power to
detect a
slope of
0.0099d
All 500,378
(100%)
81 (100%) 68 (100%) 55 124 0.97 1.00
61338 ppm-years 494,348
(98.8%)
78 (96%) 65 (96%) 54 121 0.82 1.00
61000 ppm-years 489,694
(97.9%)
75 (93%) 62 (91%) 53 117 0.78 1.00
6500 ppm-years 469,876
(93.9%)
68 (84%) 58 (85%) 50 116 0.41 0.97
6400 ppm-years 461,234
(92.2%)
63 (78%) 54 (79%) 49 111 0.44 0.96
6300 ppm-years 445,524
(89.0%)
57 (70%) 50 (74%) 46 108 0.37 0.89
6200 ppm-years 419,682
(83.9%)
48 (59%) 45 (66%) 43 105 0.26 0.70
6100 ppm-years 364,411
(73.8%)
41 (51%) 38 (56%) 36 106 0.10 0.25
a Using US male mortality rates.
b Standardized mortality ratio (SMR).
c Using the Beaumont and Breslow (1981) approach, the statistical power to detect increases in leukemia deaths in the UAB cohorts, when the expected number of cancer
deaths is based on a speciﬁed slope (coefﬁcient of BD cumulative ppm-years in the linear rate ratio model) is given by the probability of a standard normal random variable
exceeding 1.645  2  (RR0.51)  (Expected)0.5 where RR is the ratio of the number of leukemia deaths predicted to the number of leukemia deaths observed and Expected is
the number of leukemia deaths expected to occur due to background leukemia rates.
d 0.0099 is the value of the slope used in USEPA (2002).
R.L. Sielken Jr., C. Valdez-Flores / Regulatory Toxicology and Pharmacology 60 (2011) 332–341 339excess risks would be less under several alternative exposure val-
ues based on Sathiakumar et al. (2007).
Graff et al. 2009 (which is a portion of Delzell et al. 2006) eval-
uates the impact of potential inaccuracies in the 2000 exposure
estimates and conducted uncertainty analyses of the relation be-
tween cumulative exposure to BD and leukemia. They found that
the relation was maintained even when the entries in the JEM
matrices were replaced by random percentiles from the approxi-
mate probability distributions for the plant-, work area/job
group-, and year speciﬁc exposure values.
5.6. Review of other analyses
The analyses reported in Delzell et al. (1995, 1996),
Sathiakumar et al. (1998) and USEPA (2002) are based on the
outdated 1995 data set.
Delzell et al. (2001) and Sielken and Valdez-Flores (2001) are
based on the outdated 2000 data set and Poisson regression
modeling.
Cheng et al. (2007) is based on the 2004 data set and uses Cox
regression. The paper considered BD HITs as well as cumulative BD
ppm-years and concluded that high intensity exposure to BD isTable 7
Impact of alternative exposure values (job-exposure-matrix (JEM) values) on the character
exposure estimation error reported by Sathiakumar et al. (2007) and the distributional c
response modeling including cumulative BD ppm-years but no covariates.
Data set Description of JEM values b
Original Average in Macaluso distribution 2.911E-
First alternate Sathiakumar average calendar-year
correction before 1984 and average
calendar-year correction after 1983
1.469E-
Second Alternate Sathiakumar average calendar-year
correction for 1977 through 1983 and
average calendar-year correction for
1984 through 1991
2.478E-
Third alternate Sathiakumar calendar-year speciﬁc
correction for 1977 through 1991
2.468E-
Fourth Alternate Sathiakumar overall 10% correction 2.620E-important for leukemia. Cheng et al. (2007) reported an estimated
regression coefﬁcient (2.9  104) for cumulative BD ppm-years in
the Cox regression with no covariates which is identical to the
coefﬁcient calculated and reported in Table 1 herein.
The analyses in our current paper reﬁne and extend the analy-
ses done in Sielken et al. (2007). Both papers use the same UAB
study data. The numerical risk characterizations for total leukemia
are quite similar; namely, an environmental EC(1/1000) in the
2007 paper of 11.2 ppm BD which, using linear extrapolation, cor-
responds to an EC(1/100,000) of 0.112 ppm BD that is approxi-
mately equal to the 0.15 ppm BD obtained herein. The 2007
analyses were based on Poisson regression (which treats all vari-
ables as categorical) and focused on ECs calculated using only
one co-variable (BD Peaks which are now, more accurately, re-
ferred to as BD HITs). On the other hand, the current analyses are
based on Cox regression (which treats cumulative BD ppm-years
continuously instead of categorically and treats age exactly instead
of categorically), and the ECs are calculated using each one of the
six statistically signiﬁcant co-variables. In both papers, for total
leukemia, the statistical signiﬁcance of the slope for cumulative
BD ppm-years disappears when exposures are restricted to no
more than 200 or 300 cumulative BD ppm-years, and the slopeizations of the model slope parameter (b) and the excess risk estimates: Based on the
haracterization of JEM values in the UAB dataset (Macaluso et al. 2004): Exposure–
Standard deviation
of estimate of b
95% LCL on b 95% UCL on b
04 1.029E-04 1.218E-04 4.604E-04
04 5.210E-05 6.120E-05 2.326E-04
04 8.660E-05 1.054E-04 3.902E-04
04 8.620E-05 1.050E-04 3.886E-04
04 9.260E-05 1.097E-04 4.143E-04
Table 8
Maximum likelihood estimate of the slope for cumulative BD ppm-years (in the Cox proportional hazards model for CLL with cumulative BD ppm-years as a continuous variable
and the only exposure variable), standard error, conﬁdence interval, and statistical signiﬁcance for different maximum levels of cumulative BD ppm-years for deaths in which CLL
is the primary cause of death or a contributing cause of death.
Person-years and cumulative butadiene ppm-
years intervals included in the estimation
Number of
CLL deaths
Maximum likelihood
estimate of the slope
Standard error of the
estimate of the slope
95% conﬁdence
interval on the slope
Likelihood ratio test
that slope = 0 (p-Value)
All 25 0.00042 0.00013 0.00017 0.00067 0.0195*
61338 ppm-years 24 0.00160 0.00057 0.00048 0.00272 0.0145*
61000 ppm-years 23 0.00210 0.00073 0.00067 0.00353 0.0110*
6500 ppm-years 20 0.00411 0.00147 0.00123 0.00699 0.0101*
6400 ppm-years 18 0.00403 0.00192 0.00027 0.00779 0.0505
6300 ppm-years 14 0.00033 0.00352 0.00657 0.00723 0.9253
6200 ppm-years 12 0.00560 0.00661 0.01856 0.00736 0.3625
6100 ppm-years 11 0.00195 0.01090 0.02331 0.01941 0.8568
* Statistically signiﬁcant at the 5% signiﬁcance level.
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signiﬁcant co-variable are not statistically signiﬁcantly different
than zero. The current paper evaluates AML, CLL, CML, and total
leukemia whereas the 2007 paper only evaluated total leukemia
(as well as lymphoid and myeloid neoplasms in sensitivity
analyses).6. Conclusions
The ﬁt of the ﬁnal models for total leukemia, AML, CML, and CLL
did not improve with lagged cumulative exposures.
In the ﬁnal Cox models (Tables 1–3), the non-exposure covari-
ates (years since hire, calendar year, race, and plant) did not signif-
icantly improve the maximum likelihood (although calendar year
and plant are important determinants of the values in the job
exposure matrices).
For total leukemia, six exposure covariates (cumulative BD HITs,
cumulative STY HITs, cumulative STY >50 ppm, cumulative STY
650 ppm, cumulative DMDTC, and cumulative BD >100 ppm) sig-
niﬁcantly improve the maximum likelihood. Before any of the
exposure covariates are added to the Cox model for leukemia,
the slope per cumulative BD ppm-years is statistically signiﬁcantly
different than zero; however, the slope per cumulative BD ppm-
years is not statistically signiﬁcantly different than zero after any
one of the exposure covariates is added to the Cox model.
For CLL, the slope per cumulative BD ppm-years is statistically
signiﬁcantly different than zero. No exposure or non-exposure
covariate signiﬁcantly improves the maximum likelihood.
For CML, the slope per cumulative BD ppm-years is not statisti-
cally signiﬁcantly different than zero. Cumulative BD HITs signiﬁ-
cantly improves the maximum likelihood for CML. When
cumulative BD HITs is added to the Cox model, the maximum like-
lihood estimate of the slope per cumulative BD ppm-years is
negative.
For AML, the slope per cumulative BD ppm-years is not statisti-
cally signiﬁcantly different than zero. Three exposure covariates
(cumulative STY HITs, cumulative STY >50 ppm, and cumulative
DMDTC) signiﬁcantly improve the maximum likelihood for AML.
The maximum likelihood estimate of the slope per cumulative
BD ppm-years is negative in the Cox models either with or without
one of these three exposure covariates.
For both total leukemia (Tables 5 and 6) and CLL (Table 8), the
slope in the model with cumulative BD ppm-years as the only
exposure variable is not statistical signiﬁcantly different than zero
when the exposure–response modeling is based on the person-
years with cumulative BD ppm-years less than or equal to
300 ppm-years. The sensitivity analyses of the modeling to either
including or excluding other/unknown and unspeciﬁed leukemia
types as part of CLL did not change this result.For leukemia and CLL, the EC(1/100,000)s are approximately
0.15 ppm environmental BD and 0.375 ppm environmental BD,
respectively, and the corresponding URFmles are approximately
0.00007 per ppm and 0.000027 per ppm, respectively. Thus, the ex-
cess risk for CLL is approximately 2.5-fold less than for total leuke-
mia. Analogously, for leukemia and CLL, the LEC(1/100,000)s are
approximately 0.06 and 0.25 ppm environmental BD, respectively,
and the corresponding URFubs are approximately 0.00016 per ppm
and 0.00004 per ppm, respectively. Comparing bounds instead of
maximum likelihood estimates, the excess risk for CLL is approxi-
mately 4-fold less than for total leukemia.
Because the EC(1/100,000)s are approximately 0.15 and
2.3 ppm environmental BD for leukemia and CML, respectively,
and the slope per cumulative BD ppm-years for CML is not signif-
icantly different than zero, the maximum likelihood estimates sug-
gest that the excess risk for CML is approximately 15-fold less than
for total leukemia.
The maximum likelihood estimates suggest that there is no ex-
cess risk for AML from cumulative BD ppm-years.
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